About Inspire Medical Systems
Inspire Medical Systems develops a fully implanted and FDA-approved neurostimulation system for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses neurostimulation technologies and incorporates a propriety algorithm that stimulates key airway muscles based on a patient's unique breathing patterns.
Missing: Inspire Medical Systems's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Inspire Medical Systems's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Inspire Medical Systems
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Inspire Medical Systems is included in 4 Expert Collections, including Sleep Health & Wellness.
Sleep Health & Wellness
These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Inspire Medical Systems Patents
Inspire Medical Systems has filed 1 patent.
Implants (medicine), Neuroprosthetics, Sleep disorders, Medical devices, Medical technology
Implants (medicine), Neuroprosthetics, Sleep disorders, Medical devices, Medical technology
Latest Inspire Medical Systems News
Nov 17, 2022
MassDevice Search this website Axonics, Outset lead medtech space on Deloitte’s list of fastest growing companies November 16, 2022 Deloitte today released its “ North America Technology Fast 500 ” list of growing companies, including a handful of medtech firms. The list, which ranking of the fastest-growing North American companies across a range of sectors, included several “Life Sciences” outfits. Immunology company Vir Biotechnology led the way in first place on the list. Axonics (Nasdaq:AXNX) represented the highest-ranked medical device company at No. 4. According to Deloitte, the company registered 25,401% growth over a three-year period. Axonics reported $180.3 million in revenue in fiscal 2021, compared to $707,000 in fiscal 2018. The company topped last year’s version of the list. Axonics develops novel products for adults with bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and/or fecal incontinence with long-lived, easy-to-use, safe, clinically effective therapy. The company also markets Bulkamid, a urethral bulking hydrogel. “Axonics is proud to be recognized as one of the fastest-growing companies in North America,” Axonics CEO Raymond W. Cohen said in a news release. “The strong growth of Axonics is a testament to the mission-driven culture of the company, the dedication of our employees, and our commitment to continuous innovation. We have built a company that values diversity, quality, integrity, and teamwork. We remain focused on increasing awareness for Axonics’ best-in-class incontinence solutions, which have the potential to significantly improve the quality of life for millions of adults with bladder and bowel dysfunction.” Outset Medical makes the list Outset Medical (Nasdaq:OM) placed No. 33 on the Deloitte list. It recorded 5,012% growth over the three-year period. Outset brought in $103 million in revenues last year. San Jose, California-based Outset develops the Tablo hemodialysis system for kidney patients. The FDA-cleared connected and intelligent device offers two-way communication with the cloud. This allows for the sending of treatment data electronically. Physicians can remotely monitor patients so they feel connected to the medical team while comfortably remaining at home. The first-of-its-kind technology aims to reduce the cost and complexity of dialysis. Outset Chair and CEO Leslie Trigg said continued Tablo adoption in the acute and home markets drew its 2021 revenue growth. “Dialysis is a huge expense and burden on patients and providers,” said Trigg. “Tablo represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. We are honored to be recognized for our growth and share this award with all of our employees, partners, patients, physicians and families who are on the journey with us to improve the lives of kidney patients everywhere.” Pulmatrix nears the top 50 Lexington, Massachusetts-based Pulmatrix (Nasdaq:PULM) placed at No. 51 on the list. It registered growth of 3,278% from 2018 to 2021. Pulmatrix develops the patented iSperse technology. It designed iSperse to improve therapeutic delivery to the lungs. It maximizes local concentrations and reduces systemic side effects to improve patient outcomes. One indication Pulmatrix is pursuing is an orally inhaled migraine treatment. Others in the Deloitte Fast 500 Sight Sciences: 550% growth Inspire Medical Systems: 361% growth Inspire Medical Systems develops sleep apnea treatment technology. Tandem Diabetes Care: 282% growth Tandem Diabetes Care develops automated insulin delivery technology for people with diabetes. Fourteen medical devices ranging from patient monitoring to surgical robotics recently made it into Time magazine’s Best Inventions of 2022. For over 20 years, Time magazine has highlighted the 100 most impactful devices and ideas around the world. The list is compiled through nominations from the publication’s editors and global correspondents, with special attention to… […] Affera started in 2014 with a simple goal that paid off when Medtronic (NYSE:MDT) bought the company for up to $1 billion this year. Achieving that goal, however, took some unconventional and sometimes difficult design choices, Affera founder and CEO Doron Harlev said. Newton, Massachusetts–based Affera’s system diagnoses, maps and treats heart arrhythmias with ablation.… […] Viant today said it has completed the expansion of its Design & Development West Center of Excellence in Fremont, California. The facility’s footprint is now 67% larger, totaling 25,000 sf² across two buildings co-located with the company’s complex molding and assembly facility. The expansion triples the amount of ISO 8 and ISO 7 cleanroom space… […] Tecomet announced that it entered into a strategic partnership with additive manufacturer Precision ADM. Woburn, Massachusetts-based Tecomet’s partnership with Canada-based Precision ADM expands development and production opportunities. It will address both areas of additive and subtractive manufacturing. Specifically, Tecomet said in a news release that it focuses on the growth of additive manufacturing across medical… […] Schivo announced last week that it acquired APN Global and its APN Inc. operating subsidiary for an undisclosed amount. Waterford, Ireland-based Schivo said in a news release that the acquisition further solidifies its presence in North America. It also allows APN to continue growing in Quebec. The company will become the Schivo Group’s manufacturing center… […] Could robotics-led injection molding support manufacturing of the estimated 2 million different kinds of medical devices on the market? Nigel Smith, TM Robotics The COVID-19 pandemic led to a surge in demand for medical devices across hospitals and medical laboratories, and business analyst Mercer Capital predicts this growth will continue. Its Five Trends to Watch… […] Researchers at the University of Connecticut recently shared their development of a new method for charging brain stimulators. A report in Cell Reports Physical Sciences last month highlighted a charging method using a person’s own breathing movements. This could alleviate the issues caused by the surgery required each time an implantable deep brain stimluator’s batteries need changing.… […] A Stanford Medicine study observed the apparent curing of diabetes in mice following transplantation of insulin-secreting pancreatic islet cells. Researchers say the animals’ immune systems accepted the donated cells prior to transplantation. This occurs through a three-pronged process they say they could easily replicate in humans. The mice did not need immune-suppressing treatments after the… […] Donatelle (New Brighton, Minnesota) recently announced the opening of a new 2,600-square-foot ISO 7 clean room. The new space expands the contract manufacturer’s clean room facilities for Class I, Class II and Class III medical devices. In addition, it extends its high-volume production capabilities to support tens of millions more components per year. The clean… […] 3D printer accessibility and affordability are enabling small device firms to develop and market a wave of personalized devices. Gaurav Manchanda, Formlabs Healthcare is becoming more efficient, and patients are beginning to expect a personalized approach. 3D printing isn’t a newly minted manufacturing technology, yet it’s reached an inflection point for bringing change in healthcare… […]
Inspire Medical Systems Web Traffic
Inspire Medical Systems Rank
Inspire Medical Systems Frequently Asked Questions (FAQ)
When was Inspire Medical Systems founded?
Inspire Medical Systems was founded in 2007.
Where is Inspire Medical Systems's headquarters?
Inspire Medical Systems's headquarters is located at 5500 Wayzata Blvd., Golden Valley.
What is Inspire Medical Systems's latest funding round?
Inspire Medical Systems's latest funding round is IPO.
How much did Inspire Medical Systems raise?
Inspire Medical Systems raised a total of $109M.
Who are the investors of Inspire Medical Systems?
Investors of Inspire Medical Systems include Novo Ventures, U.S. Venture Partners, Synergy Life Science Partners, Kleiner Perkins Caufield & Byers, OrbiMed Advisors and 9 more.
Who are Inspire Medical Systems's competitors?
Competitors of Inspire Medical Systems include NeuroPace, Verily Life Sciences, Theranica, Orchestra BioMed, Stimdia Medical, Cala Health, Lungpacer Medical, Saluda Medical, Cardionomic, Rune Labs and 48 more.
Compare Inspire Medical Systems to Competitors
SetPoint Medical is developing a bioelectronic medicine platform using a small implanted device that activates the body's natural Inflammatory Reflex and produces a systemic anti-inflammatory effect.
Neuros Medical focuses on the development of proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, focuses on the treatment of chronic pain in a variety of applications including post-amputation pain, chronic post surgical pain, and chronic migraine.
Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.
Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.
Relievant provides the underserved population with a low-risk therapy that can eliminate back pain while preserving other therapeutic options. The Company's Intracept System is a minimally invasive procedure that uses radiofrequency energy delivered through a small access tube into the vertebral body to ablate the Basivertebral nerve. The nerve, thought to significantly contribute to chronic low back pain, can no longer generate pain signals following ablation. The company was founded in 2004 and is based in Minneapolis, Minnesota.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.